🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Thilao is a multi-country, phase 2b, non-randomized study, in Burkina Faso,...
Status
Unknown
Location
CHU Sourô Sanou
Start Date
2013-03
Trial ID
NCT02025868
This study aims to verify the persistent control of the virus replication a...
Status
Completed
Location
Policlinico A. Gemelli
Start Date
2009-08
Trial ID
NCT00958100
Treatments Being Tested
Dolutegravir (DTG) is a well-tolerated 2nd generation integrase strand tran...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-11-18
Trial ID
NCT04019873
Treatments Being Tested
The purpose of this study is to describe the effectiveness of Darunavir/ Co...
Status
Completed
Location
Azienda Ospedaliera Papa Giovanni XXIII
Start Date
2018-06-13
Trial ID
NCT03577470
Treatments Being Tested
The purpose of this study is to show if a dose of T-20 added to an anti-HIV...
Status
Completed
Location
Carlton Clinic
Start Date
TBD
Trial ID
NCT00021554
Treatments Being Tested
The purpose of this study is to compare the change in viral load (amount of...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
TBD
Trial ID
NCT00008528
Treatments Being Tested
The purpose of this study is to evaluate tolerability of darunavir (PREZIST...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01615601
Treatments Being Tested
Tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD) is being used m...
Status
Completed
Location
Les Centres GHESKIO CRS (30022)
Start Date
2019-10-28
Trial ID
NCT04050449
This study is being conducted to determine if the uptake of anti-HIV medica...
Status
Completed
Location
Hope Clinic
Start Date
2019-03-13
Trial ID
NCT03976752
Treatments Being Tested
The purpose of this research study is to learn about levels of antiretrovir...
Status
Completed
Location
The University of North Carolina at Chapel Hill
Start Date
2008-03
Trial ID
NCT00666055
Treatments Being Tested